Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Building A Telomere-to-Telomere Human Pangenome Reference

    Mar 2, 2021, 14:37 PM by User Not Found
    Bio-IT World | Our current version of the human reference genome does not adequately represent genetic diversity in the human population, Karen Miga told the virtual audience at this week’s AGBT General Meeting. The Human Pangenome Reference Consortium and the Telomere-to-Telomere Consortium are working to change that.
    Full story
  • Updates To All of Us, First Genomic Results Returned To Participants

    Mar 1, 2021, 16:51 PM by User Not Found
    Bio-IT World | Josh Denny, CEO of NIH’s All of Us program, gave an update on the population sequencing program in the opening session of the virtual AGBT General Meeting this week.
    Full story
  • Evolving Risks, Insecure Defaults, Watering Hole Threats: New Research from Accurics Uncovers Developing Sources of Cloud Risk

    Mar 1, 2021, 09:38 AM by
    Full story
  • Formulationbio: A Leading Manufacturer of Excipients for Pharmaceutical Preparation

    Mar 1, 2021, 09:38 AM by
    A good choice of excipient can lead to the formulation of stable dosage forms. To better meet the increasing demand for excipients, Formulationbio supplies a wide range of excipients for different research purposes, including binders, lubricants, diluents, disintegrants, emulsifiers, plasticizers, surfactants, sweeteners, fillers, stabilizers and so on.
    Full story
  • Caroline O’Connor becomes new CCO of rare disease healthtech Raremark® amid rapid growth

    Mar 1, 2021, 09:38 AM by
    Full story
  • Global rare disease specialist Raremark® appoints healthtech trailblazer Dale Jessop as new CTO

    Mar 1, 2021, 09:38 AM by
    Full story
  • Ashfield Healthcare Communications rebrands as Ashfield Health, launches two new global agencies and appoints former McCann Health Americas head as Global President.

    Mar 1, 2021, 09:38 AM by
    • Former 19-year McCann Health veteran, latterly President of the Americas, Amar Urhekar, joins as Global President of the >1,450 people-strong Ashfield Health network. • Ashfield Digital and Creative (UK), Cambridge BioMarketing (US) and Pegasus (UK) merge to form Mind+Matter, a new global, data-driven creative communications agency. • Ashfield Health’s 14 medical and scientific communications agencies come together to create Ashfield MedComms, a new 700 strong global powerhouse. • Ashfield Health agencies unified by common brand identity and shared new purpose to ‘make it matter’
    Full story
  • Europital board forewarns that clinical deficits to slow biotech development in 2021

    Mar 1, 2021, 09:38 AM by
    Full story
  • John Snow Labs Announces Inaugural Healthcare NLP Summit in Response to Industry Demand

    Mar 1, 2021, 09:38 AM by
    John Snow Labs announces first-ever Healthcare NLP Summit, being held virtually from April 6-9.
    Full story
  • Ashfield Engage launches with an integrated offering to maximize engagement with patients, HCPs and payers

    Mar 1, 2021, 09:38 AM by
    Full story
  • SeqOnce Biosciences Announces RT-qPCR Assay to Detect SARS-CoV-2 N501Y Variant

    Mar 1, 2021, 09:38 AM by
    SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
    Full story
  • AARDEX Group and Pill Connect Ltd Partner to Empower Patient Adherence

    Mar 1, 2021, 09:34 AM by
    Full story
  • CloudLIMS Announces Collaboration with Folio for Secure Issuance of COVID-19 Results to Patients

    Mar 1, 2021, 09:34 AM by
    CloudLIMS’ COVID-19 LIMS solution has integrated with Folio's mobile app to enable receiving, storing, and sharing of COVID-19 test results securely and digitally.
    Full story
  • NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-pyrimidine inhibitors of malaria parasite Plasmodium falciparum dihydrofolate reductase (PfDHFR).

    Mar 1, 2021, 09:34 AM by
    In recent research at BIOTEC1 a three-step fragment-based screening of PfDHFR was undertaken employing Key Organics BIONET Premium library containing 1163 fragments. This library was chosen over other commercial ones as it is rule-of-three compliant and was curated from any PAINS and aggregating compounds. All fragments are also soluble at 200 mM in DMSO and display high diversity.
    Full story
  • ComputaBio is Capable to provide Drug Design Services

    Mar 1, 2021, 09:32 AM by
    ComputaBio, a US supplier of computational biology services, claims to be a capable helping hand in drug design for industrial and academic scientists worldwide to expedite their drug development projects.
    Full story
  • VisualDx Launches Project IMPACT to Address Racism and Implicit Bias in Medicine

    Mar 1, 2021, 09:32 AM by
    Full story
  • IntelyCare Hires David Burke as CFO to Drive Business Growth and Momentum; Address Intensifying Staffing Demands in Post-Acute Space

    Mar 1, 2021, 09:32 AM by
    IntelyCare hires David Burke as chief financial officer to support the continued success and expansion of the company.
    Full story
  • Alfa Chemistry: T,C&A Lab Unveils Ingredient Analysis Service

    Mar 1, 2021, 09:32 AM by
    Full story
  • Creative Biostructure Performs Comprehensive Lead Discovery and Optimization Solutions

    Mar 1, 2021, 09:32 AM by
    Full story
  • BOC Sciences Strengthens the Cooperation with Global Biotechnology Companies to Promote ADCs Development & Research

    Mar 1, 2021, 09:32 AM by
    Full story
  • «
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178 (current)
  • 179
  • 180
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy